AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMLODIPINE / VALSARTAN / HYDROCHLOROTHIAZIDE
48 registrations across 5 African markets— 18 active
Markets with AMLODIPINE / VALSARTAN / HYDROCHLOROTHIAZIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SARTEX HCT 5MG/160MG/12,5MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | EXPHA LTD | active | Dec 2027 |
| SARTEX HCT 10MG/160MG/25MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | EXPHA LTD | active | Dec 2027 |
| SARTEX HCT 5MG/160MG/25MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | EXPHA LTD | active | Dec 2027 |
| SARTEX HCT 10MG/160MG/12,5MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | EXPHA LTD | active | Dec 2027 |
| EXFORGE HCT-5/160/12.5 | 🇷🇼Rwanda | — | active | Aug 2026 |
| EXFORGE HCT-10/160/12.5 | 🇷🇼Rwanda | — | active | Aug 2026 |
| EXFORGE HCT 5MG/160MG/25MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jan 2026 |
| EXFORGE HCT 10MG/160MG/12.5MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jan 2026 |
| EXFORGE HCT 5MG/160MG/12.5MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jan 2026 |
| SENERGY PLUS 5 MG/160-25 MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | UNITED PHARMACEUTICALS MANUFACTURE CO LTD | expired | Jan 2026 |
| SENERGY PLUS 5MG/160-12,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | MS PHARMA | expired | Jan 2026 |
| SENERGY PLUS 10MG/160MG/12,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | MS PHARMA | expired | Jan 2026 |
| CO-AMSTAN 5MG/160MG/25MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SCILIFE PHARMA (PVT) LTD | expired | Oct 2024 |
| CO-AMSTAN 5MG/160MG/12,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SCILIFE PHARMA (PVT) LTD | expired | Oct 2024 |
| CO-AMSTAN 10MG/160MG/12,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SCILIFE PHARMA (PVT) LTD | expired | Oct 2024 |
| CO-AMSTAN 10MG/160MG/25MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SCILIFE PHARMA (PVT) LTD | expired | Oct 2024 |
| TRIOVARSAN 5MG/160MG/12,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | BEKRA PHARMA UK LTD | expired | Jun 2024 |
| TRIOVARSAN 5MG/160MG/25MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | BEKRA PHARMA UK LTD | expired | Jun 2024 |
| TRIOVARSAN 10MG/160MG/25MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | BEKRA PHARMA UK LTD | expired | Jun 2024 |
| TRIOVARSAN 10MG/160MG/12,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | BEKRA PHARMA UK LTD | expired | Jun 2024 |
| AMVA+HCT DENK 5MG/160MG/12,5MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Feb 2024 |
| AMVA+HCT DENK 10MG/160MG/25MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Feb 2024 |
| AMVA+HCT DENK 10MG/160MG/12,5MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Feb 2024 |
| DUOFOR PLUS Comprimé pelliculé / 5mg/160mg/25 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Feb 2021 |
| DUOFOR PLUS Comprimé pelliculé / 5mg/160mg/12.5 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Feb 2021 |
| DUOFOR PLUS Comprimé pelliculé / 10 mg/160mg/12.5mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Feb 2021 |
| EXVALS PLUS 10MG/160MG/12,5MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | PHARMACEUTICAL INSTITUTE | expired | Jan 2021 |
| SENERGY PLUS 10 MG/160-25 MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | UNITED PHARMACEUTICALS MANUFACTURE CO LTD | expired | Jan 2021 |
| AMLO-VH 5MG/12,5MG/160MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | GENERIC HEALTHCARE PVT. LTD | expired | Jan 2020 |
| AMLO-VH 10MG/25MG/160MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | GENERIC HEALTHCARE PVT. LTD | expired | Jan 2020 |
| AMLO-VH 10MG/12,5MG/160MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | GENERIC HEALTHCARE PVT. LTD | expired | Jan 2020 |
| AMLO-VH 5MG/25MG/160MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | GENERIC HEALTHCARE PVT. LTD | expired | Jan 2020 |
| EXFORGE HCT Comprimé pelliculé / 5 mg/160mg/12.5mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Feb 2015 |
| EXFORGE HCT Comprimé pelliculé / 10 mg/160mg/12.5mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Feb 2015 |
| EXFORGE HCT Comprimé pelliculé / 10 mg/160mg/25mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Feb 2015 |
| EXFORGE HCT Comprimé pelliculé / 5 mg/160mg/25mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Feb 2015 |
| EXFORGE HCT 5MG/160MG/12.5MG COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| EXFORGE HCT 10MG/160MG/25MG COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| EXFORGE HCT 10MG/160MG/12.5MG COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| AMZVAL 5MG/160MG/25MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SEFIER LIFE SCIENCE PRIVATE LIMITED | active | — |
| CARDIOVALAM H 10MG/160MG/25MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | EXPHAR S.A | active | — |
| CARDIOVALAM H comprimé pelliculé sécable / 10 mg / 160 mg / 25 mg | 🇸🇳Senegal | EXPHAR SA | active | — |
| AMZVAL 10MG/160MG/12,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SEFIER LIFE SCIENCE PRIVATE LIMITED | active | — |
| AMZVAL 10MG/160MG/25MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SEFIER LIFE SCIENCE PRIVATE LIMITED | active | — |
| AMZVAL 5MG/160MG/12,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SEFIER LIFE SCIENCE PRIVATE LIMITED | active | — |
| EXFORGE HCT 5MG/160MG/25MG COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| AMZVAL comprimé pelliculé / 10 mg / 160 mg / 25 mg | 🇸🇳Senegal | SEFIER LIFESCIENCE | active | — |
| CARDIOVALAM H comprimé pelliculé sécable / 10 mg / 160 mg / 25 mg | 🇸🇳Senegal | EXPHAR SA | active | — |
AMLODIPINE / VALSARTAN / HYDROCHLOROTHIAZIDE in Africa — Regulatory Overview
AMLODIPINE / VALSARTAN / HYDROCHLOROTHIAZIDE is registered across 5 African markets with 48 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Tunisia, Morocco, Senegal and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 48 registrations, 18 (38%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.